All Stories

  1. Theranostic Potential of [177Lu]Lu-DOTA-Tocilizumab in Multiple Myeloma: A Preclinical Evaluation

    Article • Anti-Cancer Agents in Medicinal Chemistry, September 2026, Bentham Science Publishers

    Eloisa Riva, pablo cabral

  2. Molecular Imaging of Melanoma VEGF-expressing Tumors through [99mTc]Tc-HYNIC-Fab(Bevacizumab)

    Article • Anti-Cancer Agents in Medicinal Chemistry, November 2024, Bentham Science Publishers

    pablo cabral, Eduardo Savio

  3. 99mTechnetium- or Cy7-Labeled Fab(Tocilizumab) as Potential Multiple Myeloma Imaging Agents

    Article • Anti-Cancer Agents in Medicinal Chemistry, July 2021, Bentham Science Publishers

    Dr Hugo Cerecetto, Eloisa Riva, pablo cabral, Carlos Buchpiguel, Roger Chammas, Juan Claudio Benech

  4. Evaluation of chromosomal aberrations induced by 188Re-dendrimer nanosystem on B16f1 melanoma cells

    Article • International Journal of Radiation Biology, May 2018, Taylor & Francis

    pablo cabral, Wilner Martinez

  5. The Effect of A Hexanoic Acid Linker Insertion on the Pharmacokinetics and Tumor Targeting Properties of the Melanoma Imaging Agent 99mTc-HYNIC-cycMSH

    Article • Anti-Cancer Agents in Medicinal Chemistry, July 2017, Bentham Science Publishers

    pablo cabral

  6. Evaluation of Tricine and EDDA as Co-ligands for 99mTc-Labeled HYNIC-MSH Analogs for Melanoma Imaging

    Article • Anti-Cancer Agents in Medicinal Chemistry, December 2014, Bentham Science Publishers

    pablo cabral